Matinas Biopharma Share Price (NYSE: MTNB)
$2.33
▲
0.68
(41.21%)
Last updated on
Check the interactive Matinas Biopharma Stock chart to analyse performance
Matinas Biopharma stock performance
as on August 16, 2025 at 1:29 AM IST
- Today's Low:$1.64Today's High:$3.05
29.61%
Downside
Day's Volatility :46.23%
Upside
23.61%
- 52 Weeks Low:$0.4752 Weeks High:$7.91
79.62%
Downside
52 Weeks Volatility :94.0%
Upside
70.54%
Matinas Biopharma Stock Returns
Matinas Biopharma Holdings Inc Key Stats
Check Matinas Biopharma key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Matinas Biopharma Stock including INR - Dollar returns
The Matinas Biopharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Matinas Biopharma investment value today
Current value as on today
₹37,496
Returns
Returns from Matinas Biopharma Stock
Dollar Returns*
₹4,210 (+4.21%)
Indian investors sentiment towards Matinas Biopharma Stock
Analyst Recommendation on Matinas Biopharma Stock
Buy
88%Buy
11%Hold
0%Sell
Based on 9 Wall street analysts offering stock ratings for Matinas Biopharma(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Matinas Biopharma Share Price Target
What analysts predicted
Upside of 1187.55%
Target:
$30.00
Current:
$2.33
Matinas Biopharma share price target is $30.00, a slight Upside of 1187.55% compared to current price of $2.33 as per analysts' prediction.
Matinas Biopharma Stock Insights
Price Movement
In the last 7 days, MTNB stock has moved up by 105.3%Increasing Revenue
Revenue is up for the last 2 quarters, -1.09M → 962.0K (in $), with an average increase of 213.9% per quarterIncreasing Net Profit
Netprofit is up for the last 2 quarters, -8.43M → -1.65M (in $), with an average increase of 409.2% per quarterMTNB vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 67.4% return, outperforming this stock by 134.2%MTNB vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 96.8% return, outperforming this stock by 191.1%
Matinas Biopharma Technicals Summary
Sell
Neutral
Buy
Matinas Biopharma is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Matinas Biopharma Holdings Inc Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| 141.67% | 286.67% | -66.83% | -94.08% | -94.59% |
 | 5.56% | -14.62% | -50.77% | -8.76% | -6.46% |
 | 10.75% | 35.05% | 65.2% | 78.83% | 43.89% |
 | -15.21% | -15.0% | -17.71% | 31.27% | 43.45% |
 | 38.29% | 79.61% | 67.4% | 101.24% | 219.14% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| NA | NA | 0.0 | 0.0 | -1.93 | -0.64 | NA | 1.23 |
| 14.03 | 14.03 | 1.14 | 39.47 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.43 | -0.05 | -0.01 | NA | 34.32 |
| 27.78 | 27.78 | 0.58 | 18.05 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $8.4M | -94.59% | NA | 0.0% |
| Buy | $59.0B | -6.46% | 14.03 | 31.37% |
| NA | $37.5B | 43.89% | NA | -3.89% |
| Buy | $100.1B | 43.45% | 27.78 | 31.86% |
| Buy | $58.0B | 219.14% | NA | -12.96% |
About Matinas Biopharma Holdings Inc
Key Management of Matinas Biopharma Holdings Inc
Important FAQs about investing in MTNB Stock from India :
What is Matinas Biopharma share price today?
Matinas Biopharma share price today is $2.33 as on at the close of the market. Matinas Biopharma share today touched a day high of $3.05 and a low of $1.64.
What is the 52 week high and 52 week low for Matinas Biopharma share?
Matinas Biopharma share touched a 52 week high of $7.91 and a 52 week low of $0.47. Matinas Biopharma stock price today, is trending at $2.33, lower by 70.54% versus the 52 week high.
How to invest in Matinas Biopharma Stock (MTNB) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Matinas Biopharma on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Matinas Biopharma Shares that will get you 0.6438 shares as per Matinas Biopharma share price of $2.33 per share as on August 16, 2025 at 1:29 AM IST.
What is the minimum amount required to buy Matinas Biopharma Stock (MTNB) from India?
Indian investors can start investing in Matinas Biopharma (MTNB) shares with as little as ₹87.492 or $1 (as of August 16, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹874.92 in Matinas Biopharma stock (as per the Rupee-Dollar exchange rate as on August 16, 2025).
Based on Matinas Biopharma share’s latest price of $2.33 as on August 16, 2025 at 1:29 AM IST, you will get 4.2918 shares of Matinas Biopharma. Learn more about
fractional shares .
What are the returns that Matinas Biopharma has given to Indian investors in the last 5 years?
Matinas Biopharma stock has given -94.59% share price returns and 17.06% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?
Discover More
- Glaciershres Nsq Iceland Etf
$25.54
+0.31%
First Trust Ssi Strategi Etf$40.09
+0.25%
Uniqure Nv$16.18
+2.53%
- Blackrock Future Health Etf
$25.63
+0.2%
- Franklin Ltd Dur Inc Tr
$6.43
-0.31%
- Vaneck Gaming Etf
$44.87
-0.11%
- Netclass Technology
$1.91
+0.0%
- Trueshares Eagle Global Renewable Energy Inc Etf
$24.94
+0.65%
